Results 61 to 70 of about 70,067 (222)

Unsupervised machine learning for cardiovascular disease: A framework for future studies

open access: yesEuropean Journal of Heart Failure, EarlyView.
Unsupervised machine learning can improve the characterization and stratification of patients with cardiovascular diseases (CVDs). Clustering algorithms, which group patients based on patterns in clinical data, can reveal distinct subgroups that may differ in prognosis and treatment response.
Emmanuel Bresso   +7 more
wiley   +1 more source

Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma

open access: yesJournal of Cancer Research and Clinical Oncology
Purpose This study aimed to evaluate radiomic models’ ability to predict hypoxia-related biomarker expression in clear cell renal cell carcinoma (ccRCC).
Yijun Shao   +7 more
doaj   +1 more source

A Study on Energy Consumption in AI-Driven Medical Image Segmentation

open access: yesJournal of Imaging
As artificial intelligence advances in medical image analysis, its environmental impact remains largely overlooked. This study analyzes the energy demands of AI workflows for medical image segmentation using the popular Kidney Tumor Segmentation-2019 ...
R. Prajwal   +6 more
doaj   +1 more source

Value of 18F-FDG-PET/CT radiomics combined with clinical variables in the differential diagnosis of malignant and benign vertebral compression fractures

open access: yesEJNMMI Research, 2023
Background Vertebral compression fractures (VCFs) are common clinical problems that arise from various reasons. The differential diagnosis of benign and malignant VCFs is challenging.
Xun Wang   +8 more
doaj   +1 more source

Ultrasound-Based Radiomics Analysis for Predicting Disease-Free Survival of Invasive Breast Cancer

open access: yesFrontiers in Oncology, 2021
BackgroundAccurate prediction of recurrence is crucial for personalized treatment in breast cancer, and whether the radiomics features of ultrasound (US) could be used to predict recurrence of breast cancer is still uncertain.
Lang Xiong   +12 more
doaj   +1 more source

Sensor, Signal, and Imaging Informatics in 2017. [PDF]

open access: yes, 2018
Objective To summarize significant contributions to sensor, signal, and imaging informatics literature published in 2017.Methods PubMed® and Web of Science® were searched to identify the scientific publications published in 2017 that addressed sensors ...
Deserno, Thomas M   +3 more
core  

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer

open access: yes, 2017
Quantitative extraction of high-dimensional mineable data from medical images is a process known as radiomics. Radiomics is foreseen as an essential prognostic tool for cancer risk assessment and the quantification of intratumoural heterogeneity. In this
Aerts, Hugo J. W. L.   +11 more
core   +2 more sources

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto   +21 more
wiley   +1 more source

A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?

open access: yesnpj Precision Oncology
The search for understanding immunotherapy response has sparked interest in diverse areas of oncology, with artificial intelligence (AI) and radiomics emerging as promising tools, capable of gathering large amounts of information to identify suitable ...
Marta Ligero   +11 more
doaj   +1 more source

Cavitation of Pulmonary Metastases During Enfortumab Vedotin for Metastatic Ureteral Urothelial Carcinoma

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction Enfortumab vedotin (EV), a Nectin‐4–targeted antibody–drug conjugate, is active in previously treated urothelial carcinoma. Cavitation of pulmonary metastases is classically linked to squamous histology or anti‐angiogenic/cytotoxic regimens; rarely reported under EV.
Fumihiro Ito   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy